Global Follicle Stimulating Hormone Sales Market Report 2021
SKU ID : QYR-17364530 | Publishing Date : 09-Feb-2021 | No. of pages : 139
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
Market Analysis and Insights: Global Follicle Stimulating Hormone Market
The global Follicle Stimulating Hormone market was valued at US$ 1275.1 in 2020 and will reach US$ 1504.9 million by the end of 2027, growing at a CAGR of 2.8% during 2022-2027.
Global Follicle Stimulating Hormone Scope and Market Size
The global Follicle Stimulating Hormone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Follicle Stimulating Hormone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Recombinant FSH
Urinary FSH
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
The Follicle Stimulating Hormone market is analysed and market size information is provided by regions (countries). Segment by Application, the Follicle Stimulating Hormone market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region